TRIB2 and leukemia: Additionally, they demonstrate that TRIB2 promotes cellular efflux functions of doxorubicin by increasing the MDR1 and MRP1 cell membrane transporters, considered as “drug resistance proteins” because they work as drug efflux pump mediating multidrug resistance of human leukemia cells [97].